Neurana Pharmaceuticals, Inc. is a privately held biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, such as acute, painful muscle spasms of the back. In May 2018, Neurana completed a $60M Series A financing led by Sofinnova Ventures and included participation from New Leaf Venture Partners, H.I.G. BioHealth, and Longitude Capital.

NEURANA TEAM

The team at Neurana Pharmaceuticals is comprised of experienced biotech executives committed to bringing a novel therapy to patients suffering from muscle spasms

CRAIG THOMPSON
President & Chief Executive Officer
RANDALL KAYE,MD
Chief Medical Officer
KATHY SCOTT
Chief Financial Officer

CATHERINE BRISSON – Regulatory Affairs

JIM GALLAGHER – CMC, Manufacturing

JOHNNA HANNAH – Corporate Development

SANAM ARA VAUGHAN – Clinical Operations

TOM YONKER – Project Management

 
 

INVESTORS

 

CONTACT NEURANA

4370 La Jolla Village Drive
Suite 860
San Diego, CA 92122
United States

contact@neuranapharma.com

© 2019 Neurana Pharmaceuticals. All Rights Reserved.